Page last updated: 2024-08-25

6-amino-1-hydroxyhexane-1,1-diphosphonate and taurine

6-amino-1-hydroxyhexane-1,1-diphosphonate has been researched along with taurine in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Celli, M; D'Eufemia, P; Ferrucci, V; Finocchiaro, R; Tetti, M; Zambrano, A1
Celli, M; D'Eufemia, P; Finocchiaro, R; Iacobini, M; Raccio, I; Smacchia, P; Tetti, M; Zambrano, A1

Trials

1 trial(s) available for 6-amino-1-hydroxyhexane-1,1-diphosphonate and taurine

ArticleYear
Taurine deficiency in thalassemia major-induced osteoporosis treated with neridronate.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2010, Volume: 64, Issue:4

    Topics: Adult; beta-Thalassemia; Bone Density; Bone Density Conservation Agents; Case-Control Studies; Diphosphonates; Female; Follow-Up Studies; Humans; Male; Osteoporosis; Taurine; Time Factors; Young Adult

2010

Other Studies

1 other study(ies) available for 6-amino-1-hydroxyhexane-1,1-diphosphonate and taurine

ArticleYear
Reduction of plasma taurine level in children affected by osteogenesis imperfecta during bisphosphonate therapy.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2007, Volume: 61, Issue:4

    Topics: Amino Acids; Bone Density Conservation Agents; Child; Child, Preschool; Diphosphonates; Female; Humans; Male; Osteogenesis Imperfecta; Taurine

2007